These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32432845)

  • 41. Continuous versus intermittent infusion of vancomycin in adult patients: A systematic review and meta-analysis.
    Hao JJ; Chen H; Zhou JX
    Int J Antimicrob Agents; 2016 Jan; 47(1):28-35. PubMed ID: 26655032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Continuous Versus Intermittent Vancomycin Infusions in Infants: A Randomized Controlled Trial.
    Gwee A; Cranswick N; McMullan B; Perkins E; Bolisetty S; Gardiner K; Daley A; Ward M; Chiletti R; Donath S; Hunt R; Curtis N
    Pediatrics; 2019 Feb; 143(2):. PubMed ID: 30700564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of vancomycin target trough attainment with published dosing regimens in the neonatal intensive care unit population.
    Chung E; Lee SE; Abraham T; Saad NN; Gad A
    J Neonatal Perinatal Med; 2019; 12(1):21-27. PubMed ID: 30149480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Benefit of Individualized Vancomycin Dosing Via Pharmacokinetic Tools: A Systematic Review and Meta-analysis.
    He N; Su S; Yan Y; Liu W; Zhai S
    Ann Pharmacother; 2020 Apr; 54(4):331-343. PubMed ID: 31694384
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparison of continuous infusion versus intermittent infusion of vancomycin in patients with methicillin-resistant Staphylococcus aureus.
    Jaruratanasirikul S; Julamanee J; Sudsai T; Saengsuwan P; Jullangkoon M; Ingviya N; Jarumanokul R
    J Med Assoc Thai; 2010 Feb; 93(2):172-6. PubMed ID: 20301996
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Penetration of vancomycin into human lung tissue.
    Cruciani M; Gatti G; Lazzarini L; Furlan G; Broccali G; Malena M; Franchini C; Concia E
    J Antimicrob Chemother; 1996 Nov; 38(5):865-9. PubMed ID: 8961057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Individualized Pharmacokinetic Dosing of Vancomycin Reduces Time to Therapeutic Trough Concentrations in Critically Ill Patients.
    Truong J; Smith SR; Veillette JJ; Forland SC
    J Clin Pharmacol; 2018 Sep; 58(9):1123-1130. PubMed ID: 29957824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Retrospective Review of the Efficiency of First-Dose Therapeutic Drug Monitoring of Gentamicin, Amikacin, and Vancomycin in the Pediatric Population.
    Lim WXS; Chua WBB; Chua JM; Lee Q; Chan JW; Sultana R; Poh BH
    J Clin Pharmacol; 2020 Jan; 60(1):7-15. PubMed ID: 31448430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion.
    Vuagnat A; Stern R; Lotthe A; Schuhmacher H; Duong M; Hoffmeyer P; Bernard L
    J Clin Pharm Ther; 2004 Aug; 29(4):351-7. PubMed ID: 15271102
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Individualized vancomycin dosing in obese patients: a two-sample measurement approach improves target attainment.
    Hong J; Krop LC; Johns T; Pai MP
    Pharmacotherapy; 2015 May; 35(5):455-63. PubMed ID: 26011138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vancomycin serum concentrations do not adequately predict tissue exposure in diabetic patients with mild to moderate limb infections.
    Hamada Y; Kuti JL; Nicolau DP
    J Antimicrob Chemother; 2015 Jul; 70(7):2064-7. PubMed ID: 25802284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vancomycin Dosing and Monitoring: Critical Evaluation of the Current Practice.
    Elbarbry F
    Eur J Drug Metab Pharmacokinet; 2018 Jun; 43(3):259-268. PubMed ID: 29260505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimization of an empiric vancomycin dosing algorithm for improved target concentration attainment in patients with thermal injury.
    Hill DM; Velamuri SR; Lanfranco J; Romero Legro I; Sinclair SE; Hickerson WL
    Burns; 2019 Mar; 45(2):423-432. PubMed ID: 30340863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dosing of vancomycin and target attainment in neonates: a systematic review.
    Alrahahleh D; Xu S; Luig M; Kim HY; Alffenaar JW
    Int J Antimicrob Agents; 2022 Feb; 59(2):106515. PubMed ID: 35031450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allometric versus consensus guideline dosing in achieving target vancomycin trough concentrations.
    Brown ML; Hutchison AM; McAtee AM; Gaillard PR; Childress DT
    Am J Health Syst Pharm; 2017 Jul; 74(14):1067-1075. PubMed ID: 28522643
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and Safety of Continuous Infusion of Vancomycin in Children: A Systematic Review.
    Alonso-Moreno M; Mejías-Trueba M; Herrera-Hidalgo L; Goycochea-Valdivia WA; Gil-Navarro MV
    Antibiotics (Basel); 2021 Jul; 10(8):. PubMed ID: 34438962
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population pharmacokinetic model of Vancomycin based on therapeutic drug monitoring data in critically ill septic patients.
    Kovacevic T; Miljkovic B; Kovacevic P; Dragic S; Momcicevic D; Avram S; Jovanovic M; Vucicevic K
    J Crit Care; 2020 Feb; 55():116-121. PubMed ID: 31715528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implementation of a protocol for administration of vancomycin by continuous infusion: pharmacokinetic, pharmacodynamic and toxicological aspects.
    Ampe E; Delaere B; Hecq JD; Tulkens PM; Glupczynski Y
    Int J Antimicrob Agents; 2013 May; 41(5):439-46. PubMed ID: 23523733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients.
    Ocampos-Martinez E; Penaccini L; Scolletta S; Abdelhadii A; Devigili A; Cianferoni S; de Backer D; Jacobs F; Cotton F; Vincent JL; Taccone FS
    Int J Antimicrob Agents; 2012 Apr; 39(4):332-7. PubMed ID: 22333933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.